| __timestamp | Bausch Health Companies Inc. | Cytokinetics, Incorporated |
|---|---|---|
| Wednesday, January 1, 2014 | 2026300000 | 17268000 |
| Thursday, January 1, 2015 | 2682700000 | 19667000 |
| Friday, January 1, 2016 | 2810000000 | 27823000 |
| Sunday, January 1, 2017 | 2582000000 | 36468000 |
| Monday, January 1, 2018 | 2473000000 | 31282000 |
| Tuesday, January 1, 2019 | 2554000000 | 39610000 |
| Wednesday, January 1, 2020 | 2367000000 | 52820000 |
| Friday, January 1, 2021 | 2624000000 | 96803000 |
| Saturday, January 1, 2022 | 2625000000 | 177977000 |
| Sunday, January 1, 2023 | 2917000000 | 173612000 |
Unleashing the power of data
In the ever-evolving landscape of the pharmaceutical industry, understanding the financial strategies of key players is crucial. Over the past decade, Bausch Health Companies Inc. and Cytokinetics, Incorporated have showcased contrasting trends in their Selling, General, and Administrative (SG&A) expenses.
From 2014 to 2023, Bausch Health's SG&A expenses have seen a steady increase, peaking in 2023 with a 44% rise from 2014. This growth reflects their aggressive market expansion and strategic investments.
Conversely, Cytokinetics has experienced a staggering 900% increase in SG&A expenses over the same period. This surge underscores their commitment to innovation and market penetration, as they transition from a research-focused entity to a commercial powerhouse.
These trends highlight the diverse strategies employed by pharmaceutical companies to navigate the competitive landscape, offering valuable insights for investors and industry analysts alike.
Comparing SG&A Expenses: Novartis AG vs Cytokinetics, Incorporated Trends and Insights
Cost Management Insights: SG&A Expenses for Takeda Pharmaceutical Company Limited and Bausch Health Companies Inc.
Breaking Down SG&A Expenses: Viatris Inc. vs Cytokinetics, Incorporated
Operational Costs Compared: SG&A Analysis of Viatris Inc. and Bausch Health Companies Inc.
Summit Therapeutics Inc. vs Cytokinetics, Incorporated: SG&A Expense Trends
SG&A Efficiency Analysis: Comparing Cytokinetics, Incorporated and Alkermes plc
Who Optimizes SG&A Costs Better? Cytokinetics, Incorporated or TG Therapeutics, Inc.
Comparing SG&A Expenses: Cytokinetics, Incorporated vs Wave Life Sciences Ltd. Trends and Insights
Bausch Health Companies Inc. or Soleno Therapeutics, Inc.: Who Manages SG&A Costs Better?
Bausch Health Companies Inc. vs Iovance Biotherapeutics, Inc.: SG&A Expense Trends
SG&A Efficiency Analysis: Comparing Bausch Health Companies Inc. and Amphastar Pharmaceuticals, Inc.
Cost Management Insights: SG&A Expenses for Bausch Health Companies Inc. and BioCryst Pharmaceuticals, Inc.